IP Library Assignment 010422/0819
Patent Assignment
Reel/Frame 010422/0819

Assignment of Assignor's Interest

Recorded: 1999-12-07 Pages: 2
Assignors
RUNDFELDT, CHRIS
Executed: 1999-11-02
BARTSCH, RENI
Executed: 1999-11-05
ROSTOCK, ANGELIKA
Executed: 1999-11-03
TOBER, CHRISTINE
Executed: 1999-11-03
DOST, RITA
Executed: 1999-11-03
Assignee
ASTA MEDICA AKTIENGESELLSCHAFT
AN DER PIKARDIE 10, 01277 DRESDEN, GERMANY
Covered Property (1)
Use of Retigabine for the Treatment of Neuropathic Pain
Patent: 6,117,900 →
Application: 09/406,135 →
Related Assignments (15)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Oct 21, 2002
From: ASTA MEDICA AG
To: VIATRIS GMBH & CO. KG
Reel/Frame 013386/0851 →
Assignment of Assignor's Interest Apr 9, 2004
From: VIATRIS GMBH & CO. KG
To: XCEL PHARMACEUTICALS, INC.
Reel/Frame 015190/0447 →
Release of Security Agreement Mar 7, 2005
From: REGIMENT CAPITAL III, L.P.
To: XCEL PHARMACEUTICALS, INC.
Reel/Frame 015732/0626 →
Change of Name Jun 17, 2008
From: XCEL PHARMACEUTICALS, INC.
To: VALEANT PHARMACEUTICALS NORTH AMERICA
Reel/Frame 021109/0059 →
Security Agreement Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →
Patent Security Release Agreement Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS NORTH AMERICA; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 025950/0048 →
Security Agreement Jul 18, 2011
From: VALEANT PHARMACEUTICALS INTERNATIONAL, A DELAWARE CORPORATION; ATON PHARMA, INC., A DELAWARE CORPORATION; CORIA LABORATORIES, LTD., A DELAWARE CORPORATION; DOW PHARMACEUTICAL SCIENCES, INC., A DELAWARE CORPORATION
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 026606/0061 →
Notice of Succession of Agency Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Security Interest Jul 19, 2017
From: VALEANT PHARMACEUTICALS INTERNATIONAL
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043045/0913 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
Reel/Frame 073637/0001 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
Reel/Frame 073637/0126 →